Aditxt, Inc.
ADTX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001726711
No open-market purchases or sales by Aditxt, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Aditxt, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 12 | 11 | −1 |
| Shares | 67.2K | 4.71K | −62.5K (−93.0%) |
| Value | $826.4K | $31.2K | −$795.3K (−96.2%) |
New holders (2)
Institutions that held Aditxt, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Glassman Wealth Services | 500 | $3.31K | 0.00% |
| Game Plan Financial Advisors, LLC | 1 | $7 | 0.00% |
Sold out (3)
Institutions that held Aditxt, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Schonfeld Strategic Advisors LLC | 33,900 | $423.4K |
| Armistice Capital, LLC | 28,000 | $349.7K |
| Federation des caisses Desjardins du Quebec | 1 | $12 |